欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Teijin compound 1_226226-39-7_产品详情
226226-39-7
  • Teijin compound 1

  • names:

    Teijin compound 1

  • CAS号:

    226226-39-7

    MDL Number:
  • MF(分子式): C21H21ClF3N3O2 MW(分子量): 439.86
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Teijin compound 1
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM003570-10mg 10mg 100% ¥ 0.00 ¥ 0.00 Backorder
- +
¥ 0.00
YZM003570-5mg 5mg 100% ¥ 2470.00 ¥ 2470.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 226226-39-7
Inchi
InchiKey
分子式 Formula C21H21ClF3N3O2
分子量 Molecular Weight 439.86
溶解度Solubility 生物体外In Vitro:DMSO溶解度≥ 50 mg/mL(113.67 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知.
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
Teijin compound 1(CAS:226226-39-7)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 Teijin compound 1为CCR 2的特异性抑制剂,在趋化性和结合测定试验中IC50值分别为24和180 nM
IntroductionTeijin compound 1 is a specificCCR 2antagonist withIC50s of 24 and 180 nM in chemotaxis and binding assay, respectively.
Application1
Application2
Application3
Teijin compound 1为CCR 2的特异性抑制剂,在趋化性和结合测定试验中IC50值分别为24和180 nM。Teijin compound 1 is a specificCCR 2antagonist withIC50s of 24 and 180 nM in chemotaxis and binding assay, respectively.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Moree WJ, et al. Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series. Bioorg Med Chem Lett. 2008 Mar 15;18(6):1869-73.
【2】.Hall SE, et al. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5. Mol Pharmacol. 2009 Jun;75(6):1325-36.
【3】.Calin M, et al. VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes. Eur J Pharm Biopharm. 2015 Jan;89:18-29.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents